Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose is a prescription iron replacement therapy used to treat iron deficiency anemia when oral iron is ineffective or not tolerated. This ready-to-use vial provides a defined 500mg elemental iron dose in a sterile, 20ml container, supporting efficient replenishment of iron stores under clinical supervision.
Selecting a reliable source to buy Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose online requires attention to product authenticity, storage conditions, and compliance with medical guidance. The following sections cover product specifications, use cases, safety, and practical steps to help you make an informed decision.
| Product Name | Ferinject 500mg 20ml vial 2 x 10ml | Active Ingredient | Ferric Carboxymaltose 500mg |
|---|---|---|---|
| Form | Vial | Volume per vial | 20ml (2 x 10ml) |
| Elemental Iron per vial | 500mg | Indication | Iron deficiency anemia |
| Administration | Intravenous infusion | Prescription required | Yes |
| Storage | Room temperature, protected from light | Packaging | Glass vial with stopper |
Understanding Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose
Ferinject contains ferric carboxymaltose, a complex in which iron is bound to carboxymaltose, enabling a controlled and steady release of iron into the bloodstream. Each vial delivers 500mg of elemental iron, intended for intravenous use in a clinical environment. This formulation is designed to improve iron parameters with fewer infusion-related reactions compared to some older iron products.
When you choose to buy Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose online, you are purchasing a standardized iron therapy that must be handled by or under the direction of a licensed healthcare provider. The product is indicated for patients who require rapid iron repletion, such as those with chronic kidney disease, inflammatory bowel disease, or post-surgical recovery affecting iron absorption.
Product specifications and packaging details
Clear specifications help ensure correct dosing, compatibility, and safe handling of Ferinject. Reviewing these details before you buy Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose supports appropriate use and minimizes the risk of administration errors.
Key specifications at a glance
| Specification | Detail | Clinical relevance | Notes |
|---|---|---|---|
| Active ingredient | Ferric carboxymaltose 500mg | Iron replacement | Elemental iron content per vial |
| Volume | 20ml total (2 x 10ml vials) | Dosing flexibility | Each vial contains 500mg iron |
| Concentration | 25mg elemental iron per ml | Dilution guidance | Check local guidelines for infusion protocols |
| Route of administration | Intravenous infusion | Prescribed by clinician | Not for oral or subcutaneous use |
| Storage conditions | Room temperature, avoid light | Maintain stability | Do not freeze; use before expiry |
Clinical uses and treatment approach
Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose is typically used when oral iron therapy fails, is poorly tolerated, or when a faster correction of iron stores is clinically appropriate. Conditions such as chronic kidney disease, heart failure, and inflammatory disorders can increase iron deficiency risk, making intravenous therapy a practical option under medical supervision.
Before initiating therapy, clinicians assess iron status through laboratory tests, including ferritin, transferrin saturation, and hemoglobin levels. The dosing schedule may vary based on body weight, severity of deficiency, and underlying condition, ensuring that each patient receives a safe and effective regimen tailored to their needs.
Safety, precautions, and monitoring
Common adverse reactions associated with Ferinject include mild infusion-related symptoms such as headache, nausea, and joint or muscle pain. Serious hypersensitivity reactions are rare but require immediate medical intervention. Patients should inform their healthcare provider about allergies, history of asthma, or cardiovascular conditions prior to treatment.
Regular monitoring of iron indices and renal function is recommended during and after therapy. This helps clinicians adjust subsequent doses and avoid issues related to iron overload. Patients are advised not to self-administer and to seek professional guidance when planning treatment cycles, especially when considering buying Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose online.
Practical guidance for considering Ferinject therapy
- Confirm iron deficiency through laboratory testing before starting therapy.
- Discuss your medical history, including kidney function and allergies, with your clinician.
- Plan for intravenous administration in a clinical setting when you buy Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose.
- Follow scheduled monitoring appointments to track iron levels and treatment response.
- Report any unusual symptoms promptly to ensure timely intervention and dose adjustments.
FAQ
Reader questions
Is Ferinject 500mg 20ml vial 2 x 10ml suitable for treating severe iron deficiency anemia?
Yes, it is commonly used for significant iron deficiency anemia when oral iron is insufficient, under medical supervision with appropriate dosing and monitoring.
How quickly can hemoglobin levels improve after starting Ferinject infusions?
Many patients see improvements in hemoglobin within 2–4 weeks, depending on baseline iron status, adherence to dosing, and underlying health conditions.
Can I buy Ferinject 500mg 20ml vial 2 x 10ml ferric carboxymaltose without a prescription online?
No, this product requires a valid prescription, and it should only be used after a qualified clinician evaluates your iron status and supervises administration.
What should I do if I experience side effects after an infusion?
Contact your healthcare provider immediately for guidance, and seek urgent care for severe symptoms such as difficulty breathing, chest pain, or widespread rash.